## Abstract ## Aims We compared success rates, subsequent complications, and possible indications for success of sacral neuromodulation (SNM) for urinary voiding dysfunction in diabetic and nonβdiabetic patients. ## Methods Thirtyβtwo diabetic patients (mean age 61.8 years, range 27β83) with urg
β¦ LIBER β¦
SACRAL NEUROMODULATION FOR THE TREATMENT OF REFRACTORY VOIDING DYSFUNCTION IN THE ELDERLY POPULATION
β Scribed by White, Wesley M; Mobley, Joe D; Doggweiler, Regula; Dobmeyer-Dittrich, Cindy; Klein, Frederick A.
- Book ID
- 123135974
- Publisher
- Lippincott Williams and Wilkins
- Year
- 2009
- Tongue
- English
- Weight
- 49 KB
- Volume
- 181
- Category
- Article
- ISSN
- 0022-5347
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sacral neuromodulation in diabetic patie
β
David H. Daniels; Charles R. Powell; Matthew R. Braasch; Karl J. Kreder
π
Article
π
2009
π
John Wiley and Sons
π
English
β 92 KB
Re: Sacral Neuromodulation in Diabetic P
β
Wein, Alan J.
π
Article
π
2011
π
Lippincott Williams and Wilkins
π
English
β 56 KB
Unilateral versus bilateral stage I neur
β
Khanh Pham; Michael L. Guralnick; R. Corey O'Connor
π
Article
π
2008
π
John Wiley and Sons
π
English
β 77 KB
## Abstract ## Aims To determine if bilateral S3 lead placement during the stage I trial period improves the βsuccessβ rate for advancing to stage II (permanent) sacral neuromodulator placement. ## Methods A retrospective chart review of 124 (20 male and 104 female) patients undergoing stage I s
Sacral Root Neuromodulation in the Treat
β
H. Shaker; M. M. Hassouna
π
Article
π
1999
π
Springer
π
English
β 65 KB
483 TREATMENT OF VOIDING DYSFUNCTION BY
β
F. Van Rey; P.J.H. Jongen; J.P.F.A. Heesakkers
π
Article
π
2009
π
Elsevier Science
π
English
β 523 KB
W1653 Sacral Neuromodulation for the Tre
β
El-Gazzaz, Galal S.; Salcedo, Levilester B.; Zutshi, Massarat; Hull, Tracy L.
π
Article
π
2008
π
Elsevier Science
π
English
β 156 KB